Herbas VPB

Print
EN | LT
LT - Difluorlaktamo junginiai, tokie kaip EP4 receptoriaus selektyvūs agonistai, skirti naudoti EP4 sąlygotų ligų ir būsenų gydymui
EN - DIFLUOROLACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASE AND CONDITIONS

Legal status

Patent lapsed (non-payment of fees)

Bibliographic data
Indications of the International Patent Classification (IPC)
(51) INT.CL. C07D 409/06 (2006.01)
C07D 207/26 (2006.01)
C07D 403/12 (2006.01)
C07D 207/20 (2006.01)
A61K 31/4015 (2006.01)
A61K 31/4025 (2006.01)
A61P 27/02 (2006.01)
A61P 27/06 (2006.01)
A61P 25/02 (2006.01)
A61P 17/14 (2006.01)
A61P 19/10 (2006.01)
European patent
(11) Number of the document 2875022
(13) Kind of document T
(96) European patent application number 13745744.6
Date of filing the European patent application 2013-07-19
(97) Date of publication of the European application 2015-05-27
(45) Date of publication and mention of the grant of the patent 2016-10-12
(46) Date of publication of the claims translation 2017-03-10
PCT application
(86) Number PCT/US2013/051263
Date 2013-07-19
PCT application publication
(87) Number WO 2014/015247
Date 2014-01-23
Priority applications
(30) Number Date Country code
201261673514 P 2012-07-19 US
201361793929 P 2013-03-15 US
Inventors
(72)
BARRETT, Stephen, Douglas, US
CISKE, Fred, Lawrence, US
COLOMBO, Joseph, Michael, US
ENDRES, Gregory, William, US
GERMAIN, Bradlee, David, US
KORNILOV, Andriy, US
KRAMER, James, Bernard, US
UZIEBLO, Adam, US
MAXEY, Kirk, M., US
Grantee
(73) Cayman Chemical Company, Incorporated, 1180 E. Ellsworth Road, Ann Arbor, Michigan 48108, US
Attorney or representative
(74) Liudmila GERASIMOVIČ, IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius, LT
Title
(54) Difluorlaktamo junginiai, tokie kaip EP4 receptoriaus selektyvūs agonistai, skirti naudoti EP4 sąlygotų ligų ir būsenų gydymui
  DIFLUOROLACTAM COMPOUNDS AS EP4 RECEPTOR-SELECTIVE AGONISTS FOR USE IN THE TREATMENT OF EP4-MEDIATED DISEASE AND CONDITIONS
Last renewal fee
Payment date Validity (years) Amount
2019-07-08 7 162.00 EUR
Legal status
Patent lapsed (non-payment of fees)
Invalidation date 2020-07-19